The top diplomats of China, South Korea and Japan will meet in Tokyo for talks this weekend, the three East Asian countries ...

This is the first such attempt on a commercial unit in Japan, after Chubu Electric decided in 2008 to dismantle two reactors ...

Representatives from politics, business and science have signed a Memorandum of Understanding (MOU) to establish a ...

A unique exchange program is linking the Tri-Cities with universities in Japan, focusing on the shared nuclear history of both regions.

The FTSE 100 company, which has a market capitalisation of £185.9 billion, confirmed the deal in an announcement to the London Stock Exchange on Monday. AstraZeneca was advised by a Covington team led ...

Initial results found that among 1060 participants in 30 countries, the pembrolizumab plus CCRT group conferred better PFS at 24 months than the placebo plus CCRT group (68% vs 57%; hazard ratio [HR], ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community. This summit brings together cutting-edge innovators from Asia alongside ...

The pharma will acquire Araris Biotech to gain access to three preclinical ADCs and a linking technology Araris claims is superior to existing platforms.